Asia has seen remarkable revivals in private equity investment and fundraising – though not in exits – over the past three months. A handful of large-cap situations mask a weak environment
J-Star's acquisition of Pepper Lunch is driven by a willingness to look past COVID-19 dislocations and focus on the long-term fundamentals of the fast-casual dining space in Japan
EQT has submitted a revised offer to acquire New Zealand retirement village player Metlifecare at a lower valuation after facing a legal challenge over its attempt to terminate a previously agreed deal.
Japanese private equity firm J-Star has acquired regional restaurant chain Pepper Lunch for an undisclosed sum.
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.
The Rise Fund, TPG’s impact investment business, has purchased solar projects with a combined capacity of 970 megawatts from China-based Trina Solar for approximately $700 million.
Japan’s Accordia Golf, which was acquired by MBK Partners in 2017, has agreed a S$804.1 million ($577 million) privatization of a Singapore-listed trust it established six years ago as the holding entity for 88 golf courses.
CLSA Capital Partners (CLSA CP) has acquired Assist, a Japanese marketplace that facilitates sourcing helpers for daily household jobs.
The Carlyle Group is willing to invest as much as $210 million in SeQuent Scientific to get a head start in India's rapidly evolving animal healthcare industry
Japan Industrial Partners (JIP) has agreed to acquire Olympus Corporation’s camera and lens business, which has posted losses in each of the last three years.
Bain Capital has entered into an agreement to acquire and recapitalize beleaguered airline Virgin Australia Holdings (VAH).
Grindr, America's most popular LGBTQ dating app, was only put up for sale because its Chinese owner violated foreign investment regulations. San Vicente's subsequent $560 million acquisition faced intense scrutiny
Will Chinese companies listed in the US become the latest casualties of tensions between the two countries? It could lead to a narrowing in IPO exit options for PE and VC investors
Australian private equity firm Five V Capital has acquired a controlling stake in New Zealand employee management software provider Totara for an undisclosed sum.
Sydney-based private equity firm Mercury Capital has agreed to acquire the Australia and New Zealand assets of Germany’s Bauer Media, including an extensive magazine portfolio.
58.com, China’s leading online classifieds marketplace, has agreed to be acquired by a consortium of private equity investors at an implied equity valuation of $8.7 billion.
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
BGH Capital has agreed to acquire the primary care business of Australia’s Healius – comprising medical centers, GP practices, and dental clinics – for an enterprise valuation of A$500 million ($341 million).
CVC Capital Partners is looking to acquire majority control of Indian cancer care center operator HealthCare Global Enterprises (HCG) in a deal that could be worth up to IN10.4 billion ($$138.9 million).
Private equity investors expect to see more divestments by Asian conglomerates, but a torrent of new deals is unlikely. Much rests on when the seller is confident enough to pull the trigger
Baring Private Equity Asia, which already holds a majority stake in Indian IT services provider Hexaware Technologies, is offering to privatize the business at a valuation of INR85 billion ($1.1 billion).
A Dymon Asia Private Equity (DAPE)-backed privatization of Malaysia’s Yee Lee Group – which did not proceed last year – has been reactivated at a reduced valuation of MYR394.7 million ($92.4 million).
Following its investment in Duncan Solutions in 2018, Anacacia Capital is helping the parking management systems provider tap into demand arising from Australia’s smart city movement
Health and safety was a priority when IMM Private Equity negotiated a $413 million carve-out of Korea Kolmar Holdings' drug outsourcing business against the backdrop of COVID-19